Imatinib in Pulmonary Arterial Hypertension: C-Kit Inhibition

Pulmonary Circulation - United States
doi 10.1086/677359
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

KIT Inhibition by Imatinib in Patients With Severe Refractory Asthma

New England Journal of Medicine
Medicine
2017English

Arrhythmias in Pulmonary Arterial Hypertension

Journal of Congenital Cardiology
2017English

EZH2 Inhibition Ameliorates Transverse Aortic Constriction-Induced Pulmonary Arterial Hypertension in Mice

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Pulmonary Arterial Hypertension in Children

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Trends in Pulmonary Arterial Hypertension

European Respiratory Review
PulmonaryRespiratory Medicine
2009English

Heritable Pulmonary Arterial Hypertension

2020English

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Pathophysiology

European Respiratory Review
PulmonaryRespiratory Medicine
2010English

Other Causes of Pulmonary Arterial Hypertension: Pulmonary Veno-Occlusive Disease, Pulmonary Capillary Hemangiomatosis, Porto-Pulmonary Hypertension, HIV- Associated Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy